Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    


Nashville Biosciences Launches


 
Leeland Ekstrom, PhD

VUMC Harnesses Power of Genomic, Bioinformatics Resources

Last month, officials with Vanderbilt University Medical Center (VUMC) announced the creation of a wholly owned subsidiary, Nashville Biosciences, to harness the power of its extensive genomic and bioinformatics resources to advance drug and diagnostics discovery and development.

Through Nashville Biosciences, pharmaceutical and other life science companies can leverage the wealth of data contained within VUMC's genomics and health information technology resources to accelerate the discovery and development of new treatments for patients, while helping to support institutional research efforts.

"Partnering with the pharmaceutical and broader life sciences industry through Nashville Biosciences will enable VUMC to expand and support its mission of advancing translational and precision medicine," said Leeland Ekstrom, PhD, founder and chief operating officer of Nashville Biosciences.

The new company will serve as a commercial interface between outside companies and the formidable research resources housed in VUMC, including its comprehensive databank BioVU® which contains more than 250,000 DNA samples collected over the last decade, coupled with 2.8 million de-identified patient records.

"The creation of Nashville Biosciences will dramatically accelerate our ability to work with pharmaceutical and other partners to advance human health by accelerating rational drug and diagnostics development and use," added Dan Roden, MD, VUMC's senior vice president for Personalized Medicine.

Among the capabilities that will distinguish the company are analytical methods developed for "mining" DNA datasets. For example, researchers led by Josh Denny, MD, MS, vice president of Personalized Medicine, have pioneered techniques such as PheWASTM that can link specific genetic mutations to their key clinical characteristics (known as disease phenotypes).

Among academic medical centers, VUMC is widely recognized as a leader in the application of genomics and bioinformatics to drug development, an effort that is transforming the pharmaceutical industry, Ekstrom said. Even before the launch of Nashville Biosciences, VUMC has already been working closely with a number of top pharmaceutical and diagnostic companies including Pfizer, Celgene Corporation, Population Bio, and Goldfinch Bio. These projects, each of which aims to discover new treatments for patients in disease areas of interest for each partner, as well as multiple other ongoing efforts, will transition to the new company in the coming weeks.

"We've only just started to scratch the surface of what is possible with genomics and informatics resources that can be coalesced for research in a comprehensive academic medical center," said Gordon Bernard, MD, executive vice president for Research for VUMC. "Partnering with Nashville Biosciences will greatly expand the national and global reach of these resources."


WEB:

Nashville Biosciences

 
Share:

Related Articles:


Recent Articles

ACEP Statement on Texas High School Shooting

WASHINGTON -- In response to the high school shooting today in Santa Fe, Texas, Dr. Paul Kivela, president of the American College of Emergency Physicians (ACEP) issued the following statement:

Read More

AMA Marks Milestone in Medical Education As First Students Graduate Under Transformative National Curricula Redesign Initiative

First medical students who received training under national effort begin to graduate this month, including students from NYU, Indiana University, East Carolina University, Oregon Health and Science University, Penn State

Read More

Study Tracks Impact of Neonatal Abstinence Syndrome on State Medicaid Programs 

In the United States, one infant is born every 15 minutes with withdrawal symptoms after being exposed to opioids before birth, according to a new study published in the journal Pediatrics.

Read More

Read More

ACEP Board To Consider Further Legal Recourse During May Meeting

The federal government last week published a notice of clarification in response to a court order requiring it to adequately address comments and proposals made by the American College of Emergency Physicians (ACEP) and other organizations regarding the Greatest of Three Rule.

Read More

National Nurses Week: Lipscomb Prepares Next Generation of Servant Nurses

Every day nurses play a significant role in the nation's healthcare, and this week the nation is celebrating the profession as part of the American Nurses Association annual National Nurses Week celebration.

Read More

Healing Mind & Body

Experts say screenings, education, early intervention key to improving, maintaining mental health.

Read More

Searching for Sustainable Solutions to the Physician Shortage

AAMC calls for a multi-pronged approach to address the looming physician shortage.

Read More

Statement On Opioid Related Legislation

America's hospitals and health systems have been engaged in treating people with substance use disorders for decades. In recent years, we have seen first-hand the devastating effects of the opioid epidemic on patients, families, and communities across the country.

Read More

New Legislation Addressing the Opioid Crisis

As the latest session of the Tennessee Legislature drew to a close, new laws were passed impacting the prescribing of opioids, particularly in regards to 'opioid naïve' patients.

Read More

Email Print
 
 

 

 


Tags:
Bioinformatics, Drug Development, Genomic Data, Leeland Ekstrom, Nashville Biosciences, Pharmaceutical Research, Vanderbilt University Medical Center, VUMC
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: